Ethical Issues of Gene Therapy

The world trade market for cell and gene based therapies is expected to greater than the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell based therapies are high impact disease areas with significant incurable needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases gene therapies should then not be rushed to market but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers.

 

    Related Conference of Ethical Issues of Gene Therapy

    February 24-25, 2025

    19th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    April 03-04, 2025

    15th International Conference on Human Genetics and Genetic Diseases

    Madrid, Spain
    April 03-04, 2025

    18th International Conference on Genomics & Pharmacogenomics

    Madrid, Spain
    April 14-15, 2025

    8th Annual Conference on Stem Cell and Regenerative Medicine

    Budapest, Hungary
    April 29-30, 2025

    3rd International Conference on Cell Science and Molecular Biology

    Barcelona, Spain
    May 19-20, 2025

    8th Global Conference on Cell and Gene Therapy

    Singapore City, Singapore
    June 12-13, 2025

    13th World Congress on Human Genetics and Genetic Diseases

    London, UK
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany
    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain

    Ethical Issues of Gene Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in